| 44633-6 |
Tumor pigmentation |
Prid |
Skin melanoma |
Pt |
Nom |
|
|
ACTIVE |
Tumor pigmentation |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.SKIN |
|
44633-6 |
|
|
|
|
Observation |
|
|
|
0 |
Tumor pigmentation |
|
|
|
N |
|
Dermatologic; Epidermis; Identity or presence; Integument; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS SKIN; Point in time; Random; Skn |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocols" and the copyright since this is not a CAP-specific concept. Added example answer list. |
0 |
| 44634-4 |
Reason invasive component size cannot be determined |
Find |
Breast tumor |
Pt |
Nar |
|
|
ACTIVE |
Reason invasive component size cannot be determined in Breast tumor Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44634-4 |
|
|
|
|
Observation |
|
|
|
0 |
Reas inv comp size not det BT |
|
|
|
N |
|
Brst; BT; Cancer; Finding; Findings; Narrative; PATH.HISTO; PATHOLOGY; Point in time; Random; Reas inv comp size not det; Report; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Updated Component from "Invasive component size.cannot be determined" to clarify meaning, removed Method of CAP because this is not a CAP-specific term, and changed Property from Arb to Find. |
0 |
| 44635-1 |
Invasive component size.max.dimension |
Len |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Invasive component size.maximum dimension [Length] in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.HISTO |
|
44635-1 |
|
|
|
|
Observation |
|
|
|
0 |
Inv comp size max dim BT |
|
|
|
N |
|
Brst; BT; Cancer; Inv comp size max dim; Largest; Length; Maximal; Maximum; PATH.HISTO; PATHOLOGY; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44636-9 |
Invasive component size.additional dimension 1 |
Len |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Invasive component size additional dimension 1 [Length] in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.HISTO |
|
44636-9 |
|
|
|
|
Observation |
|
|
|
0 |
Inv comp size addl dim 1 BT |
|
|
|
N |
|
Add; Brst; BT; Cancer; i; Inv comp size addl dim 1; Length; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Size addl dim; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44637-7 |
Invasive component size.additional dimension 2 |
Len |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Invasive component size additional dimension 2 [Length] in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.HISTO |
|
44637-7 |
|
|
|
|
Observation |
|
|
|
0 |
Inv comp size addl dim 2 BT |
|
|
|
N |
|
Add; Brst; BT; Cancer; II; Inv comp size addl dim 2; Length; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Size addl dim; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44638-5 |
Histologic type |
Type |
Breast tumor |
Pt |
Nom |
|
|
ACTIVE |
Histologic type in Breast tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44638-5 |
|
|
|
|
Observation |
|
|
|
0 |
Histo type BT |
|
|
|
N |
|
Brst; BT; Cancer; Histo type; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; tumors; tumour; tumours; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed the Copyright and Method of CAP since this is not a CAP-specific concept, and added Term description |
0 |
| 44639-3 |
Histologic type |
Type |
Prostate tumor |
Pt |
Nom |
|
|
ACTIVE |
Histologic type in Prostate tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44639-3 |
|
|
|
|
Observation |
|
|
|
0 |
Histo type PrT |
|
|
|
N |
|
Cancer; Histo type; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific concept. Also changed answer list from "Normative" to "Preferred" |
0 |
| 4464-4 |
Spermatozoa evaluation.cervical mucus penetration test |
Imp |
Semen |
Pt |
Nom |
|
|
ACTIVE |
Cervical Mucus Penetration Test [Interpretation] in Semen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
FERT |
|
4464-4 |
|
|
|
|
Observation |
|
|
|
0 |
CMSPT Smn-Imp |
|
|
|
|
|
Assessment; Cerv; CMSPT; Cvx Mucus; Ejaculate; Eval; FERTILITY TESTING; Genitourinary; GU; H&P; History and physical; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Mucous; Mucous Threads; Nominal; Point in time; Post coital test; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology |
2.26 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 44640-1 |
Histologic type |
Type |
Skin melanoma |
Pt |
Nom |
|
|
ACTIVE |
Histologic type in Skin melanoma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44640-1 |
|
|
|
|
Observation |
|
|
|
0 |
Histo type Mel |
|
|
|
N |
|
Dermatologic; Epidermis; Histo type; Integument; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Skn; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific term. Also added answer list. |
0 |
| 44641-9 |
Gleason pattern.primary |
Type |
Prostate tumor |
Pt |
Nom |
|
|
ACTIVE |
Gleason pattern.primary in Prostate tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44641-9 |
|
|
|
|
Observation |
|
|
|
0 |
Gleason.primary PrT |
|
|
|
N |
|
Cancer; Gleason.primary; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific concept. |
0 |
| 44642-7 |
Gleason pattern.secondary |
Type |
Prostate tumor |
Pt |
Nom |
|
|
ACTIVE |
Gleason pattern.secondary in Prostate tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44642-7 |
|
|
|
|
Observation |
|
|
|
0 |
Gleason.secondary PrT |
|
|
|
N |
|
Cancer; Gleason.secondary; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific concept. |
0 |
| 44643-5 |
Gleason pattern.tertiary |
Type |
Prostate tumor |
Pt |
Nom |
|
|
ACTIVE |
Gleason pattern.tertiary in Prostate tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44643-5 |
|
|
|
|
Observation |
|
|
|
0 |
Gleason.tertiary PrT |
|
|
|
N |
|
Cancer; Gleason.tertiary; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours; Typ |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific concept. |
0 |
| 44644-3 |
Tubule formation |
Arb |
Breast tumor |
Pt |
Ord |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Tubule formation in Breast tumor by CAP cancer protocols |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44644-3 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Tubule formation BT CAP prot |
|
|
|
N |
|
Arbitrary; Brst; BT; Cancer; CAP prot; Ordinal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; QL; Qual; Qualitative; Random; Screen; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 44645-0 |
Nuclear pleomorphism |
Score |
Breast tumor |
Pt |
SemiQn |
Nottingham |
|
ACTIVE |
Nuclear pleomorphism in Breast tumor by Nottingham |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44645-0 |
|
Nottingham |
|
|
Observation |
|
|
|
0 |
Nuc pleomorph BT Nottingham |
|
|
|
N |
|
Brst; BT; Cancer; Nuc; Nuc pleomorph; PATHOLOGY; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; Random; Scale; SmQn; tumors; tumour; tumours |
2.75 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of CAP because this concept is part of the Nottingham histologic score, and added Method of Nottingham. Also updated Property from Arb to Score and added Normative answer list. |
0 |
| 44646-8 |
Nottingham mitotic count.25x obj |
Find |
Breast tumor |
Pt |
Nom |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Nottingham mitotic count.25x obj in Breast tumor by CAP cancer protocols |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44646-8 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Nottingham mitotic count.25x |
|
|
|
N |
|
Brst; BT; Cancer; CAP prot; Finding; Findings; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; Random; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 44647-6 |
Nottingham mitotic count.40x obj |
Find |
Breast tumor |
Pt |
Nom |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Nottingham mitotic count.40x obj in Breast tumor by CAP cancer protocols |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44647-6 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Nottingham mitotic count.40x |
|
|
|
N |
|
Brst; BT; Cancer; CAP prot; Finding; Findings; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; Random; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 44648-4 |
Histologic grade |
Score |
Breast cancer specimen |
Pt |
SemiQn |
Nottingham |
|
ACTIVE |
Histologic grade [Score] in Breast cancer specimen by Nottingham |
|
MAJ |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
PATH.HISTO |
|
44648-4 |
|
Nottingham |
|
|
Observation |
|
|
|
0 |
Histo grade Score Br ca spec Nottingham |
|
|
|
N |
|
Br ca spec; Brst; CA; Ca spec; Histo grade; PATH.HISTO; Pathology; Point in time; Random; Scale; SmQn; Spec |
2.75 |
2.17 |
|
|
|
|
|
|
|
{score} |
|
|
Removed CAP Copyright and Method because this concept is not specific to CAP, moved Nottingham from Component to Method, changed System from "Breast tumor" because the concept is specific to breast cancer, added answer list |
0 |
| 44649-2 |
Grading system |
Find |
Breast tumor |
Pt |
Nom |
|
|
ACTIVE |
Grading system in Breast tumor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44649-2 |
|
|
|
|
Observation |
|
|
|
0 |
Grading system BT |
|
|
|
N |
|
Brst; BT; Cancer; Finding; Findings; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; Random; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocol" and copyright since this is not a CAP-specfic concept and updated Scale from Nar |
0 |
| 4465-1 |
Spermatozoa evaluation.hamster ova penetration test |
Imp |
Semen |
Pt |
Nom |
|
|
ACTIVE |
Hamster Ova Penetration Test [Interpretation] in Semen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
FERT |
|
4465-1 |
|
|
|
|
Observation |
|
|
|
0 |
SPA Smn-Imp |
|
|
|
|
|
Assessment; Ejaculate; Eval; FERTILITY TESTING; Genitourinary; GU; H&P; Hamster Zona-Free Ovum Test; History and physical; Humster Test; HZFO Test; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Ovum; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; SPA; Sperm; Sperm penetration assay; URO; Urology |
2.26 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 44650-0 |
Mitotic count per 10 HPF |
Area |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Mitotic count per 10 HPF in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44650-0 |
|
|
|
|
Observation |
|
|
|
0 |
Mitotic count /10 HPF BT |
|
|
|
N |
|
Brst; BT; Cancer; Mitotic count /10 HPF; PATHOLOGY; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; QNT; Quan; Quant; Quantitative; Random; tumors; tumour; tumours |
2.69 |
2.17 |
|
|
|
|
|
|
|
/[HPF] |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44651-8 |
Tissue cores.positive.carcinoma |
Num |
Tissue core |
Pt |
Qn |
|
|
ACTIVE |
Tissue cores.positive.carcinoma in Tissue core |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44651-8 |
|
|
|
|
Observation |
|
|
|
0 |
Tissue cores.pos.Ca Tissue Core |
|
|
|
N |
|
Cnt; Count; Number; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Pos; QNT; Quan; Quant; Quantitative; Random; Tissue cores.pos.Ca |
2.69 |
2.17 |
|
|
|
|
|
|
|
{#} |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44652-6 |
Total number of cores |
Num |
Tissue core |
Pt |
Qn |
|
|
ACTIVE |
Total number of cores in Tissue core |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44652-6 |
|
|
|
|
Observation |
|
|
|
0 |
Total # of cores Tissue Core |
|
|
|
N |
|
Cnt; Count; No; Num; Number; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Total # of cores; Totl |
2.69 |
2.17 |
|
|
|
|
|
|
|
{#} |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44653-4 |
Tumor quantitation.incidental |
Find |
Prostate tumor |
Pt |
Nom |
CAP cancer protocols |
|
ACTIVE |
Tumor quantitation.incidental in Prostate tumor by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44653-4 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Tumor quant.incident PT CAP prot |
|
|
|
N |
|
Cancer; CAP prot; Finding; Findings; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Prost; Prostatic; PrT; Random; Tumor quant.incidental; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 44654-2 |
Prostatic tissue involved by tumor |
NFr |
Prostate tumor |
Pt |
Qn |
|
|
ACTIVE |
Tissue involved by tumor in Prostate tumor |
|
MAJ |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44654-2 |
|
|
|
|
Observation |
|
|
|
0 |
Tissue involved by tumor PrT |
|
|
|
N |
|
Cancer; Intraglandular extent; Number fraction; PATHOLOGY; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Percent; Point in time; Prost; Prostate; Prostati; Prostatic; PrT; QNT; Quan; Quant; Quantitative; Random; tumors; tumour; tumours |
2.58 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
| 44655-9 |
Tissue chips.positive.carcinoma |
Num |
Tissue chip |
Pt |
Qn |
|
|
ACTIVE |
Number of carcinoma positive tissue chips CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44655-9 |
|
|
|
|
Observation |
|
|
|
0 |
# CA pos tissue chips CAP prot |
|
|
|
N |
|
Cnt; Count; Number; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Pos; QNT; Quan; Quant; Quantitative; Random; Tissue chips.pos.Ca |
2.69 |
2.17 |
|
|
|
|
|
|
|
{#} |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
